Here are seven takeaways:
1. The market will likely hit $49.14 billion by 2021.
2. An increasing geriatric population, growing number of osteoporosis cases and increasing number of sports injuries will boost the global orthopedic devices market.
3. The costliness of orthopedic devices, product recalls and poor economic conditions will stunt market growth, though.
4. The knee segment dominated the market by anatomical location in 2016. The hip segment, however, will see the most rapid growth through 2021.
5. In 2015, North America dominated the market, with Europe coming in second. Demand for infusion pumps and stents is driving the European market.
6. The Asia-Pacific region will see the greatest growth through 2021, due to an increasing geriatric population, obesity cases and bone conditions.
7. Major market companies include: Medtronic, Stryker, DePuy Synthes, Smith & Nephew and Zimmer Biomet.
More articles on devices:
Implanet receives FDA clearance for JAZZ braid: 5 key points
DePuy Synthes introduces single use instrument kits for wrist fracture surgery: 5 takeaways
Drs. Christopher Gilligan, Timothy Deer to discuss chronic low back pain at Mainstay Medical key opinion leader event: 4 highlights
